Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Obesity × semaglutide × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Metformin 6 Exercise 3 Liraglutide 2 Docosahexaenoic Acids 2 Diet 2 sibutramine 1 semaglutide 1 Ursodeoxycholic Acid 1 Topiramate 1 Tirzepatide 1 Propofol 1 Nutrition Therapy 1 Nutrition Assessment 1 Exenatide 1 Doxorubicin 1 Cyclophosphamide 1 Caloric Restriction 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Peking University First Hospital

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡